Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Mr. Ranjal Laxmana Shenoy (DIN 00074761) has vide letter dated 11th July, 2022 tendered his resignation as Non- Executive Independent Director of the Company with immediate effect. We wish to place on record appreciation for the valuable contributions made by him during his tenure as an Independent Director on the Board of the Company. Kindly take the same on your records.
11-07-2022
Bigul

Alkem Laboratories Ltd - 539523 - Reg. 34 (1) Annual Report.

 Please find enclosed herewith the Notice of the 48th Annual General Meeting of the Company scheduled to be held on Thursday, 25th August, 2022 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) alongwith the Annual Report for the financial year 2021-2022. The same is also available on the website of the Company at www.alkemlabs.com Kindly take the same on record.
11-07-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 This is to inform you that US FDA had conducted a GMP and Pre-Approval inspection at the Company's manufacturing facility located at Indore from 01st July, 2022 to 07th July, 2022. At the end of the inspection, the Company has received Form 483 with one (1) observation with respect to ANDA filed for the products to be manufactured at the said plant. There is no data integrity observation. This GMP and Pre-Approval Inspection is part of the routine business operations and the Company shall submit to US FDA within the stipulated timeline, a detailed response to close out the said observation. Kindly take the same on record.
07-07-2022
Bigul

Alkem Laboratories Ltd - 539523 - Statement Of Investor Complaints For The Quarter Ended June 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MANISH NARANGDesignation :- Company Secretary and Compliance Officer
06-07-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 read along with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Mumbai Lakshadweep (Marathi) for information regarding 48th Annual General Meeting of the Company to be held through video conferencing (VC)/ other audio visual means (OAVM). The same is also available on the website of the Company at www.alkemlabs.com. Kindly take the same on record.
29-06-2022
Bigul

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

 This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 29th June, 2022 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter ended 30th June, 2022 are communicated to the Stock Exchanges.
28-06-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 This is to inform you that US FDA had conducted an inspection of the Company's manufacturing facility located at St. Louis, USA from 06th June, 2022 to 17th June, 2022. At the end of the inspection, the Company has received Form 483 with three (3) observations. The Company shall submit to US FDA within the stipulated timeline, a detailed response to close out all the observations associated with this inspection. Kindly take the same on record.
18-06-2022
Bigul

Alkem Laboratories Ltd - 539523 - Disclosure Of Related Party Transactions On A Consolidated Basis Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions, on a consolidated basis, for the half year ended on 31st March, 2022 in the prescribed format. The same have been published on the website of the Company at www.alkemlabs.com. Kindly take the same on record.
25-05-2022
Bigul

Alkem Laboratories Ltd - 539523 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 In terms of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Secretarial Compliance Report for the period ended 31st March, 2022 issued by Practising Company Secretary. Kindly take the same on record.
23-05-2022

Buy Alkem Laboraties; target of Rs 3680: Motilal Oswal

 Motilal Oswal is bullish on Alkem Laboraties recommended buy rating on the stock with a target price of Rs 3680 in its research report dated May 14, 2022.
17-05-2022
Next Page
Close

Let's Open Free Demat Account